HomeAboutScientific TeamCode of Good PracticeResearchCOVID-19 TestingCardiac HealthClinical Trial Design & MethodologyHepatologyEthnic and Sex Differences Physiology & Drug ResponsesPublicationsNewsCareersSupportContact

What’s a Rich Text element? (H1)

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

What’s a Rich Text element? (H2)

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing (H3)

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text (H4)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

How to customize formatting for each rich text (H5)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

How to customize formatting for each rich text (H6)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

AASLD Liver Meeting 2025

29th July 2025

Richmond Research Institute is pleased to confirm our participation in The Liver Meeting 2025, hosted by the American Association for the Study of Liver Diseases (AASLD), taking place in Washington, DC, from 7th–11th November.

Representing Richmond at the meeting:
• James Rickard, Chief Scientific Officer

James looks forward to connecting with academic and industry leaders to discuss Richmond’s capabilities in:
• Early-phase hepatology and metabolic liver disease trials
• First-in-human and dose-ranging studies
• Non-invasive biomarkers and digital health integration
• Regulatory strategy and multi-regional trial execution
• Patient-centric approaches in complex liver disease research

Attending AASLD 2025 and looking for a trusted partner in liver disease clinical development? Contact us to arrange a meeting with James: info@richmondpharmacology.com

Related News

HFA 2025

Richmond Research Institute to present key cardiology research at Heart Failure 2025 in Belgrade, Serbia.

First patient enrolled in telehealth study, the Pathway Study

The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and...

Results of landmark gene editing study for ATTR Amyloidosis presented at the International Liver Congress 2022

Results of landmark gene editing study for ATTR Amyloidosis presented at the International Liver Congress 2022

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers

We studied the cardiac safety of P218 using advanced QTc assessments and found doses of up to 1000mg do not prolong the QTc suggesting a low risk of drug induced arrhythmia.

Effectiveness of 12-lead ECG versus Holter monitor confirmed in important trial methodology

12-lead resting ECGs are considered essential in clinical trials, but their limitations have led to increasing use of 12-lead Holter monitor devices.

Why patient safety is paramount in patient trials

Dr. Taubel explains to the New Scientist why patient safety is pivotal in phase I trials

Back to News